ADA 2025 Recap: Improving Lives
Improving Lives Breakthrough T1D’s Improving Lives program focuses on devices, insulins, adjunctive therapies, treatments for complications, and psychosocial interventions to…
Treating and preventing eye disease with type 1 diabetes
Diabetic eye disease is a troubling reality for many people living with type 1 diabetes, but research is helping reduce…
Could drugs like Ozempic also benefit people with type 1 diabetes?
Learn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help…
2024 greatest T1D hits: A glance at this year’s achievements
While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures…
FDA Advisory Committee does not recommend that sotagliflozin receive approval for glucose lowering in adults with type 1 diabetes (T1D) and Chronic Kidney Disease (CKD)
Update – November 22, 2024 This morning, Lexicon Pharmaceuticals, Inc. (Lexicon) announced they received a “deficiencies preclude discussion” letter from…
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
A Complication of Type 1: Gastroparesis
Gastroparesis is a condition when the stomach is unable to empty itself properly, leading to problems such as becoming full…
Breakthrough T1D Staff Share Personal Stories About Diabetic Eye Disease
Breakthrough T1D staff share their experiences with diabetic eye disease to help raise awareness of the importance of being proactive…
Interview: I’ve Got Hope Back in my Life
The Mary Tyler Moore Vision Initiative has a lofty goal: To halt and reverse vision loss from diabetes. Here’s one…
Moonshot Reimagined: Our Vision to Halt and Reverse Vision Loss
Breakthrough T1D has taken a bold new step to prevent and restore vision loss and blindness: Restoring Vision Moonshot, in…
